ABSTRACT
Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment.
Subject(s)
Antihypertensive Agents/adverse effects , Gastrointestinal Agents/adverse effects , Hydralazine/adverse effects , Infliximab/adverse effects , Lupus Erythematosus, Cutaneous/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Humans , Lupus Erythematosus, Cutaneous/pathology , Male , Middle Aged , Skin/pathologyABSTRACT
O penfigoide bolhoso (PB) é uma dermatose bolhosa autoimune subepidérmica que comumente afeta indivíduos idosos. O desencadeamento da doença por medicamentos é conhecido, entretanto, pouco descrito na literatura, especialmente casos associados ao uso de enalapril. A interrupção do fármaco desencadeante constitui o pilar terapêutico, entretanto medicações podem ser necessárias. Descrevemos um caso de PB em um paciente com 45 anos associado ao uso do enalapril e discutimos sobre a variante de PB induzida por medicamentos.
ABSTRACT
Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment.
.Subject(s)
Adult , Humans , Male , Middle Aged , Antihypertensive Agents/adverse effects , Gastrointestinal Agents/adverse effects , Hydralazine/adverse effects , Infliximab/adverse effects , Lupus Erythematosus, Cutaneous/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Lupus Erythematosus, Cutaneous/pathology , Skin/pathologySubject(s)
Neurofibromatosis 1/pathology , Skin Neoplasms/pathology , Abdomen , Adult , Female , Humans , Rare DiseasesABSTRACT
Esporotricose é uma infecção fúngica subcutânea, adquirida por inoculação direta, causada pelo Sporothrix schenckii. Embora a apresentação clássica linfocutânea represente a maioria dos casos, as formas clínicas atípicas e graves têm aumentado em ocorrência. Esporotricose sistêmica e esporotricose cutânea disseminada são variantes raras, usualmente associadas à imunodeficiência celular ou a estados debilitantes. Relatamos o primeiro caso na literatura de lesões molusco-símiles em esporotricose cutaneomucosa múltipla. Os exames micológico direto e histopatológico apresentavam-se ricos em células leveduriformes.
Sporotrichosis is a subcutaneous fungal infection caused by Sporothrix schenckii and acquired by direct inoculation. Although the majority of cases consist of the classic lymphocutaneous presentation, the frequency of atypical and severe clinical forms of the disease has increased progressively. Systemic and disseminated cutaneous sporotrichosis constitute rare variants and such cases are generally associated with cellular immunodeficiency or debilitated states. The present paper describes the first published case of molluscum-like lesions in disseminated mucocutaneous sporotrichosis. Direct mycological examination and histopathology revealed numerous yeast cells.
Subject(s)
Humans , Male , Middle Aged , Sporothrix , Sporotrichosis/microbiology , Sporotrichosis/pathology , Brazil , Fatal Outcome , Skin/pathology , Sporotrichosis/therapyABSTRACT
Sporotrichosis is a subcutaneous fungal infection caused by Sporothrix schenckii and acquired by direct inoculation. Although the majority of cases consist of the classic lymphocutaneous presentation, the frequency of atypical and severe clinical forms of the disease has increased progressively. Systemic and disseminated cutaneous sporotrichosis constitute rare variants and such cases are generally associated with cellular immunodeficiency or debilitated states. The present paper describes the first published case of molluscum-like lesions in disseminated mucocutaneous sporotrichosis. Direct mycological examination and histopathology revealed numerous yeast cells.
